Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1777 to 1826 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 4 isoform a; apc-stimulated guanine nucleotide exchange factor. [source:refseq;acc:nm\_015320]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.878\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.286\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0121\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-1 (homeobox protein pbx1) (homeobox protein prl). [source:swissprot;acc:p40424]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.874\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01206\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
germ cell-less. [source:refseq;acc:nm\_022471]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.877\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-3 (homeobox protein pbx3). [source:swissprot;acc:p40426]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.332\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.874\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C1orf179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hyporthetical protein mgc27169. [source:refseq;acc:nm\_176782]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEIS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein meis1. [source:swissprot;acc:o00470]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEIS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein meis2 (meis1-related protein 1). [source:swissprot;acc:o14770]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BAG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-2. [source:swissprot;acc:o95816]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-2 (homeobox protein pbx2) (g17 protein). [source:swissprot;acc:p40425]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor 4. [source:refseq;acc:nm\_025245]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEIS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein meis3 (meis1-related protein 2) (fragment). [source:swissprot;acc:q99687]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNASEH2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribonuclease hi large subunit (ec 3.1.26.-) (rnase hi large subunit) (rnase h(35)) (ribonuclease h2) (rnase h2). [source:swissprot;acc:o75792]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.539\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01205\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna topoisomerase ii, alpha isozyme (ec 5.99.1.3). [source:swissprot;acc:p11388]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.759\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.349\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01197\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1791\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 3 (hu-antigen c) (huc) (paraneoplastic cerebellar degeneration-associated antigen) (paraneoplastic limbic encephalitis antigen 21). [source:swissprot;acc:q14576]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.295\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01194\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAVL4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 4 (paraneoplastic encephalomyelitis antigen hud) (hu-antigen d). [source:swissprot;acc:p26378]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.199\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01193\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NME2P1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.823\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoside diphosphate kinase b (ec 2.7.4.6) (ndk b) (ndp kinase b) (nm23-h2) (c-myc purine-binding transcription factor puf). [source:swissprot;acc:p22392]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.138\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.861\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAVL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 2 (hu-antigen b) (hub) (elav-like neuronal protein 1) (nervous system-specific rna binding protein hel-n1). [source:swissprot;acc:q12926]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.158\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOP2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna topoisomerase ii, beta isozyme (ec 5.99.1.3). [source:swissprot;acc:q02880]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.759\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.357\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NME2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoside diphosphate kinase a (ec 2.7.4.6) (ndk a) (ndp kinase a) (tumor metastatic process-associated protein) (metastasis inhibition factor nm23) (nm23-h1). [source:swissprot;acc:p15531]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.111\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.834\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAVL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 1 (hu-antigen r) (hur). [source:swissprot;acc:q15717]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.807\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.242\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-actinin 2 (alpha actinin skeletal muscle isoform 2) (f-actin cross linking protein). [source:swissprot;acc:p35609]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.016\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.481\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01182\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYRK1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1a (ec 2.7.1.-) (protein kinase minibrain homolog) (mnbh) (hp86) (dual specificity yak1-related kinase). [source:swissprot;acc:q13627]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.011\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0118\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CUGBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cug triplet repeat rna-binding protein 1 (cug-bp1) (rna-binding protein brunol-2) (deadenylation factor cug-bp) (50 kda nuclear polyadenylated rna-binding protein) (eden-bp). [source:swissprot;acc:q92879]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.984\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.441\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elongation protein 4 homolog; pax6 neighbor gene; chromosome 11 open reading frame 19. [source:refseq;acc:nm\_019040]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.011\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.481\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYRK1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1b (ec 2.7.1.-) (mirk protein kinase). [source:swissprot;acc:q9y463]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CUGBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cug triplet repeat, rna binding protein 2; elav-type rna-binding protein; cug triplet repeat,rna-binding protein 2; cug triplet repeat, rna-binding protein 2; neuroblastoma apoptosis-related rna-binding protein. [source:refseq;acc:nm\_006561]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.984\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.442\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTN4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-actinin 4 (non-muscle alpha-actinin 4) (f-actin cross linking protein). [source:swissprot;acc:o43707]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.008\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.482\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01178\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-actinin 1 (alpha-actinin cytoskeletal isoform) (non-muscle alpha-actinin 1) (f-actin cross linking protein). [source:swissprot;acc:p12814]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.009\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RALGPS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ral guanine nucleotide exchange factor ralgps1a. [source:refseq;acc:nm\_014636]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.102\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
208.651\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01175\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RALGPS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ral-a exchange factor ralgps2. [source:refseq;acc:nm\_152663]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STUB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
stip1 homology and u-box containing protein 1; serologically defined colon cancer antigen 7; carboxy terminus of hsp70p-interacting protein; heat shock protein a binding protein 2 (c-terminal). [source:refseq;acc:nm\_005861]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1810\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lon protease homolog, mitochondrial precursor (ec 3.4.21.-) (lon protease-like protein) (lonp) (lonhs). [source:swissprot;acc:p36776]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.214\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.827\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01171\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1811\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GALNT2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polypeptide n-acetylgalactosaminyltransferase 2; udp-galnac transferase 2. [source:refseq;acc:nm\_004481]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.35\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01168\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1812\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCNC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin c. [source:swissprot;acc:p24863]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.564\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1813\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GALNTL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to expressed sequence ai415388 (fragment). [source:sptrembl;acc:q8n428]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.35\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1814\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP1CC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine protein phosphatase pp1-gamma catalytic subunit (ec 3.1.3.16) (pp-1g). [source:swissprot;acc:p36873]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
122.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
123.727\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01167\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1815\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dpy-30-like protein. [source:swissprot;acc:q9c005]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.462\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.926\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01164\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1816\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAB11FIP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rab coupling protein; rab-interacting recycling protein; rab effector protein; rab11-family interacting protein 1. [source:refseq;acc:nm\_025151]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAB11FIP5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-snap-associated factor 1; rab11-interacting protein. [source:refseq;acc:nm\_015470]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COX4NB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neighbor of cox4. [source:swissprot;acc:o43402]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C14orf122\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein c14orf122 (cgi-112). [source:swissprot;acc:q9y3b6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP9A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM38\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding region containing protein 1 (hsrnaseb) (ssdna binding protein seb4) (cll-associated antigen kw-5). [source:swissprot;acc:q9h0z9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01152\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PFKL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.085\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01151\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FXR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.086\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0115\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CAPZA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
f-actin capping protein alpha-1 subunit (capz alpha-1). [source:swissprot;acc:p52907]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.281\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FXR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.086\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUP43\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoporin nup43 (p42). [source:swissprot;acc:q8nfh3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.393\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.094\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01149\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/